Ultram
Ultram Official FDA information, side effects and uses.
Posted by Ultram (Ultram) on Fri, 10 Aug 2007 00:15:54 +0000
Boston Globe - Sales of Wellbutrin XL fell 53.5 percent on generic competition, but sales of blood pressure drug Cardizem LA, antifungal medication Zovirax and painkiller Ultram ER improved. Biovail's sales and profit topped analyst estimates, but shares fell 6.4 ...
Biovail has high hopes, sluggish results
Ottawa Sun - Partly offsetting those declines were rising sales of painkiller Ultram ER, herpes treatment Zovirax and angina drug Cardizem LA. Squires had nothing new to report on Biovail’s entanglement with the U.S. Securities and Exchange ...
Biovail's profits and sales slip in Q2
Ottawa Business Journal - As well, royalty and other revenues fell by 36.9 per cent to $4.9 million as a result of the completion of a joint promotion between Biovail's Ultram ER chronic-pain medication and prostate- and breast-cancer treatment Zoladex. However, these losses ...
Biovail Q2 Profit Declines On Lower Revenues; Reveals License And ...
Stockhouse Canada - Royalty and other revenue declined on the elimination of co-promotion revenues associated with Ultram ER and Zoladex. Separately, the company revealed that a subsidiary, Biovail Laboratories International SRL, entered into a license and development ...
Biovail Reports Second-Quarter 2007 Financial Results
CNW Group - Ultram(R) ER Patent Litigation In May 2007, Biovail Laboratories International SRL, along with Ortho-McNeil, Inc. (OMI), Purdue Pharma Products L.P., and Napp Pharmaceutical Group Ltd., initiated patent-infringement litigation against Par ...
